CDKN2A and rheumatoid arthritis: Further experimental validations also offered convincing evidence that ARF may attenuate RA partially by restoring the expression level of EGFR, MMP 9, IL2, MAPK14, and KDR and in reversing the pathological events during RA progression by regulating inflammatory factors.